Publication Name	World Journal of Gastroenterology
Manuscript ID	18156
Country	United States

Received	2015-04-09 08:36
Peer-Review Started	2015-04-09 21:55
To Make the First Decision	2015-05-18 12:52
Return for Revision	2015-05-19 20:01
Revised	2015-06-02 02:00
Second Decision	2015-08-06 21:16
Accepted by Journal Editor-in-Chief	2015-08-07 12:16
Accepted by Executive Editor-in-Chief	2015-08-31 16:09
Articles in Press	2015-08-31 16:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-10 10:59
Publish the Manuscript Online	2015-10-23 15:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Promises and paradoxes of regulatory T cells in inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	James D Lord
Funding Agency and Grant Number
Corresponding Author	James D Lord, MD, PhD, Research Assistant Member, Translational Program Benaroya Research Institute at Virginia Mason Mailstop, IN-RC 1201 Ninth Avenue, Seattle, WA 98101, United States. james.lord@vmmc.org
Key Words	Foxp3; Regulatory T cells; Crohn’s disease; Th17; Ulcerative colitis; Inflammatory bowel disease
Core Tip	Regulatory T cells (Tregs) have received much interest in animal models of inflammatory bowel disease (IBD), but have yet to demonstrate a clear defect in human Crohn’s disease or ulcerative colitis. This review will detail our current knowledge about this important regulatory arm of the immune system in human IBD, and discuss the potential role for Tregs as immunotherapy.
Publish Date	2015-10-23 15:45
Citation	Lord JD. Promises and paradoxes of regulatory T cells in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11236-11245
URL	http://www.wjgnet.com/1007-9327/full/v21/i40/11236.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i40.11236

Full Article (PDF)	WJG-21-11236.pdf
Full Article (Word)	WJG-21-11236.doc
Manuscript File	18156-Review.docx
Answering Reviewers	18156-Answering reviewers.pdf
Audio Core Tip	18156-Audio core tip.MP3
Conflict-of-Interest Disclosure Form	18156-Conflict-of-interest statement.pdf
Copyright License Agreement	18156-Copyright assignment.pdf
Peer-review Report	18156-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	18156-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	18156-Scientific misconduct check.pdf
Scientific Editor Work List	18156-Scientific editor work list.pdf